James Nathanielsz
Vermögen: 276 642 $ am 31.05.2026
Vermögen: 276 642 $ am 31.05.2026
Mr. James A. Nathanielsz is an Executive Chairman, CEO & Treasurer at Propanc Biopharma, Inc. and a Chief Executive Officer & Director at Propanc Pty Ltd. He is on the Board of Directors at Propanc Pty Ltd. Mr. Nathanielsz was previously employed as a Manager-New Products by Biota Holdings Ltd. He received his undergraduate degree from Swinburne University of Technology and a graduate degree from Swinburne University of Technology.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 16.03.2026 | 152’000 ( 6.67% ) | 276 640 $ | 31.05.2026 | |
| 16.03.2026 | 1 ( 100% ) | 2 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| PROPANC BIOPHARMA, INC. | Vorstandsvorsitzender | 15.10.2007 |
Propanc Pty Ltd.
Propanc Pty Ltd. BiotechnologyHealth Technology Engages in cancer treatment research | Gründer | 12.10.2007 |
| Unternehmen | Position | Ende |
|---|---|---|
| BIOTA HOLDINGS LTD. | Corporate Officer/Principal | 01.10.2007 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Propanc Biopharma, Inc.
Propanc Biopharma, Inc. BiotechnologyHealth Technology Operates as a development stage healthcare company which develops new cancer treatments for patients | Health Technology |
Biota Holdings Pty Ltd.
Biota Holdings Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as an anti infective drug development company | Health Technology |
Swinburne University of Technology
Swinburne University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Propanc Pty Ltd.
Propanc Pty Ltd. BiotechnologyHealth Technology Engages in cancer treatment research | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen